Nonalcoholic fatty liver disease as a component of the metabolic syndrome

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver-related morbidity and mortality. The association between NAFLD and the metabolic syndrome is well established: the presence of the metabolic syndrome signifies advanced histology in NAFLD patients. Emerging data indicate that patients with NAFLD have a significantly higher prevalence of cardiovascular disease. This article reviews the definitions of the two syndromes, their association, and the cardiovascular risk conferred by both when they occur separately and together. This review also discusses management options for the syndromes, including treating the individual components of the metabolic syndrome in NAFLD patients.

Original languageEnglish
Pages (from-to)73-80
Number of pages8
JournalCurrent Gastroenterology Reports
Volume10
Issue number1
DOIs
StatePublished - 2008

Fingerprint

Histology
Cardiovascular Diseases
Non-alcoholic Fatty Liver Disease
Morbidity
Mortality
Liver
Wells syndrome

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Nonalcoholic fatty liver disease as a component of the metabolic syndrome. / Khashab, Mouen A.; Liangpunsakul, Suthat; Chalasani, Naga.

In: Current Gastroenterology Reports, Vol. 10, No. 1, 2008, p. 73-80.

Research output: Contribution to journalArticle

@article{fb8c280d33ba41a682af9c47103564f1,
title = "Nonalcoholic fatty liver disease as a component of the metabolic syndrome",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver-related morbidity and mortality. The association between NAFLD and the metabolic syndrome is well established: the presence of the metabolic syndrome signifies advanced histology in NAFLD patients. Emerging data indicate that patients with NAFLD have a significantly higher prevalence of cardiovascular disease. This article reviews the definitions of the two syndromes, their association, and the cardiovascular risk conferred by both when they occur separately and together. This review also discusses management options for the syndromes, including treating the individual components of the metabolic syndrome in NAFLD patients.",
author = "Khashab, {Mouen A.} and Suthat Liangpunsakul and Naga Chalasani",
year = "2008",
doi = "10.1007/s11894-008-0012-0",
language = "English",
volume = "10",
pages = "73--80",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Nonalcoholic fatty liver disease as a component of the metabolic syndrome

AU - Khashab, Mouen A.

AU - Liangpunsakul, Suthat

AU - Chalasani, Naga

PY - 2008

Y1 - 2008

N2 - Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver-related morbidity and mortality. The association between NAFLD and the metabolic syndrome is well established: the presence of the metabolic syndrome signifies advanced histology in NAFLD patients. Emerging data indicate that patients with NAFLD have a significantly higher prevalence of cardiovascular disease. This article reviews the definitions of the two syndromes, their association, and the cardiovascular risk conferred by both when they occur separately and together. This review also discusses management options for the syndromes, including treating the individual components of the metabolic syndrome in NAFLD patients.

AB - Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver-related morbidity and mortality. The association between NAFLD and the metabolic syndrome is well established: the presence of the metabolic syndrome signifies advanced histology in NAFLD patients. Emerging data indicate that patients with NAFLD have a significantly higher prevalence of cardiovascular disease. This article reviews the definitions of the two syndromes, their association, and the cardiovascular risk conferred by both when they occur separately and together. This review also discusses management options for the syndromes, including treating the individual components of the metabolic syndrome in NAFLD patients.

UR - http://www.scopus.com/inward/record.url?scp=51549099280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51549099280&partnerID=8YFLogxK

U2 - 10.1007/s11894-008-0012-0

DO - 10.1007/s11894-008-0012-0

M3 - Article

C2 - 18417046

AN - SCOPUS:51549099280

VL - 10

SP - 73

EP - 80

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 1

ER -